Recombinant sea cucumber peptide with anti-aging effect as well as preparation method and application thereof

Through genetic engineering technology, Pichia cerevisiae expresses and purifies sea cucumber peptides, the problems of high price, environmental damage and immunogenic risks in sea cucumber peptide extraction technology are solved, and the high-efficiency and low-cost anti-aging effect is achieved. It is suitable for cosmetics lifting and repairing the skin fluid.

CN119060154AActive Publication Date: 2024-12-03XIAN HUIPU BIOTECH CO LTD

Patent Information

Application Number
CN202411356681.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-26
Publication Date
2024-12-03
Estimated Expiration
2044-09-26

AI Technical Summary

Technical Problem

The existing sea cucumber peptide extraction technology has the high price, low extraction yield and damage to the ecological environment. The extracts are at risk of animal immunogenicity, making it difficult to effectively utilize their anti-aging effects.

Method used

Through genetic engineering, Pichia cerevisiae is used for expression and purification to prepare recombinant sea cucumber polypeptides with anti-aging effects. The specific steps include designing the amino acid sequence and nucleotide sequence of the sea cucumber polypeptide, constructing expression vectors, performing cell-induced fermentation and protein purification. , high-purity sea cucumber peptide was prepared.

Benefits of technology

It has achieved efficient preparation of sea cucumber polypeptides, has excellent anti-aging effect, is low in cost, and avoids damage to the marine environment, reduces the risk of animal immunogenicity, and is suitable for lifting and repairing skin fluid in cosmetics.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005064505450000041
    Figure BDA0005064505450000041
  • Figure BDA0005064505450000051
    Figure BDA0005064505450000051
  • Figure BDA0005064505450000081
    Figure BDA0005064505450000081
Patent Text Reader

Abstract

The invention discloses a recombinant sea cucumber peptide with an anti-aging effect and a preparation method and application thereof, and the amino acid sequence with the anti-aging effect is SEQ ID NO.1. The preparation method of the recombinant sea cucumber peptide mainly comprises the following steps: gene synthesis; constructing a carrier plasmid: integrating the target gene sequence into the carrier plasmid, and introducing the plasmid into a competent gene engineering strain; fermenting and expressing a target product; high-purity sea cucumber peptide is obtained through purification means (solid-liquid separation, salting-out, isoelectric precipitation, chromatography technology and ultrafiltration), the sea cucumber peptide has excellent water solubility and high purity and can be widely applied to cosmetics, meanwhile, the invention provides a preparation method of the anti-aging lifting and repairing base liquid, and the product is mild in use, free of irritation and excellent in anti-aging effect.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the field of biotechnology, and in particular to a recombinant sea cucumber peptide with anti-aging effects, and a preparation method and application thereof. Background Art

[0002] Sea cucumber is a general term for animals of the class Holothuria of the phylum Echinodermata. Although sea cucumbers are cylindrical, their thickness, shape and size vary greatly from species to species. Common large edible sea cucumbers are all relatively sturdy cylindrical, with warty feet on the back and tube feet on the ventral side. The body wall of sea cucumbers is flexible and rich in connective tissue, and the thickness varies with the species. Because of its cucumber-like appearance, it is called "sea cucumber" in English. There are more than 900 species of sea cucumbers in the world, and about 140 species in China. Since ancient times, sea cucumbers have been a precious and fine product for nourishing the body and a good medicine for preventing and treating some diseases. There are many records in Chinese medical books of successive dynasties. Sea cucumbers are sweet and warm in nature. They have the effects of nourishing the kidney and essence, nourishing blood and moistening dryness, and prolonging life, which can be compared with ginseng. Sea cucumbers are one of the potential marine organisms that have a beneficial effect on human health. Modern pharmacological studies have shown that sea cucumber peptides, as a marine bioactive peptide, have multiple biologically active functions, such as anti-oxidation, anti-inflammatory, anti-fatigue, anti-tumor, immune regulation, and lowering blood pressure.

[0003] The sources of sea cucumber peptides or sea cucumber collagen on the market are all obtained by extracting sea cucumbers. On the one hand, the price of fresh sea cucumbers is relatively expensive, and the extraction yield is not very high. On the other hand, catching a large number of sea cucumbers is likely to cause damage to the ecological environment, which will have an impact on the marine environment and the ecological chain. At the same time, the extracted sea cucumber peptides or sea cucumber collagen have the risk of animal immunogenicity. Therefore, obtaining recombinant sea cucumber peptides through genetic engineering, fermentation, and purification has broad market prospects. Summary of the invention

[0004] Sea cucumber polypeptides have many physiological functions, but in the prior art, research is mainly focused on the anti-aging effect of sea cucumber polypeptides. The purpose of this application is to provide an active polypeptide with anti-aging effect derived from sea cucumbers.

[0005] The present application provides an amino acid sequence with anti-aging effect, wherein the amino acid sequence is SEQ ID NO.1, and the SEQ ID NO.1 is

[0006] GPPGGPGLGGQQGPRGPPGPSGTITLEVEPSDTIENVK.

[0007] Furthermore, the amino acid sequence is derived from sea cucumber.

[0008] The present application provides a polypeptide with anti-aging efficacy, wherein the polypeptide comprises the following amino acid sequence: (GPPGGPGLGGQQGPRGPPGPSGTITLEVEPSDTIENVK)n , n is 1, 2, 3, 4 or 5.

[0009] Furthermore, the polypeptide is derived from sea cucumber.

[0010] The present application provides a nucleotide sequence encoding the aforementioned amino acid sequence or the aforementioned polypeptide.

[0011] Furthermore, the nucleotide sequence is SEQ ID NO.6, and the SEQ ID NO.6 is

[0012] GGTCCACCAGGTGGTCCAGGTTTGGGTGGTCAACAAGGTCCAAGAGGTCCAC CAGGTCCATCTGGTACTATTACTTTGGAAGTTGAACCATCTGATACTATTGAAAAC GTTAAG.

[0013] The present application provides a method for preparing a polypeptide, wherein the polypeptide is the aforementioned polypeptide.

[0014] The method comprises:

[0015] The polypeptide is obtained by expressing and purifying Pichia pastoris, and the Pichia pastoris carries an expression vector having the nucleotide sequence of the polypeptide.

[0016] Furthermore, the Pichia pastoris is Pichia pastoris GS115, and preferably the expression vector is pPIC9K.

[0017] The present application provides the use of the aforementioned amino acid sequence or the aforementioned polypeptide or the polypeptide prepared by the aforementioned method in the preparation of cosmetics.

[0018] The present application provides a cosmetic comprising the aforementioned amino acid sequence or the aforementioned polypeptide or a polypeptide prepared by the aforementioned method.

[0019] The present application extracts a polypeptide with high anti-aging function composed of a short amino acid sequence from sea cucumbers, which has excellent anti-aging properties. The sea cucumber peptide is prepared, fermented, and purified through synthetic biology, and has the advantages of high purity, good efficacy, and low cost. By formulating a lifting and anti-aging skin base liquid, the anti-aging effect is excellent. It can be further widely used in cosmetics. BRIEF DESCRIPTION OF THE DRAWINGS

[0020] Figure 1 This is the mass spectrum obtained by mass spectrometry detection of sea cucumber polypeptides in Example 2.

[0021] Figure 2 This is the mass spectrum obtained by mass spectrometry detection of sea cucumber polypeptides in Example 2.

[0022] Figure 3 This is the plasmid map of the recombinant sea cucumber peptide in Example 4.

[0023] Figure 4 This is the hydrophilicity diagram of the recombinant sea cucumber peptide in Example 4.

[0024] Figure 5 This is a graph showing the moisture content of the skin stratum corneum before and after use of the lifting and repairing base lotion in Example 5.

[0025] Figure 6 This is a graph showing the transepidermal water loss rate of the skin before and after use of the lifting and repairing base lotion in Example 5.

[0026] Figure 7 This is a graph of skin firmness (RO) before and after using the lifting and repairing base lotion in Example 5. DETAILED DESCRIPTION

[0027] The following is a description of the exemplary embodiments of the present application, including various details of the embodiments of the present application to facilitate understanding, which should be considered as merely exemplary. Therefore, it should be recognized by those of ordinary skill in the art that various changes and modifications can be made to the embodiments described herein without departing from the scope and spirit of the present application. Similarly, for the sake of clarity and conciseness, the description of well-known functions and structures is omitted in the following description.

[0028] As used herein, the terms "polypeptide", "peptide", "sea cucumber peptide" and "sea cucumber polypeptide" are used interchangeably herein to refer to a polymer of amino acid residues. That is, the description of a polypeptide is equally applicable to describing a peptide and describing a protein, and vice versa. The terms are applicable to naturally occurring amino acid polymers and amino acid polymers in which one or more amino acid residues are non-naturally encoded amino acids. As used herein, the terms encompass amino acid chains of any length.

[0029] As used herein, the term "nucleic acid molecule" may include those containing naturally and / or non-naturally occurring nucleotides and bases, including, for example, those with backbone modifications, and refers to polymers of nucleotides, such polymers of nucleotides may contain natural and / or non-natural nucleotides, and include, but are not limited to, DNA, RNA, and PNA. Nucleotide sequence refers to the linear sequence that constitutes a nucleic acid molecule.

[0030] In some cases, the nucleic acid molecule contains cDNA, and in some cases, the nucleic acid molecule can be modified for use in the constructs described herein, such as for codon optimization. In some cases, for the purpose of cloning into a vector, the sequence can be designed to contain a terminal restriction site sequence.

[0031] In some cases, nucleic acid molecules can be obtained from a variety of sources, such as by polymerase chain reaction (PCR) amplification of encoding nucleotides within or isolated from one or more given cells.

[0032] As used herein, the term "nucleic acid", "polynucleotide" or "nucleotide" can be used generically, which means deoxyribonucleotides, deoxyribonucleosides, ribonucleosides or ribonucleotides and polymers thereof in single-stranded or double-stranded form. Unless specifically limited, the term encompasses nucleic acids containing known analogs of natural nucleotides, which have binding properties similar to reference nucleic acids and are metabolized in a manner similar to naturally occurring nucleotides. Unless otherwise specifically limited, the term also means oligonucleotide analogs, which include PNA (peptide nucleic acid), DNA analogs used in antisense technology (phosphorothioate, phosphoramidate, etc.). Unless otherwise specified, a specific nucleic acid sequence also implicitly encompasses conservatively modified variants thereof (including, but not limited to, degenerate codon substitutions) and complementary sequences as well as explicitly specified sequences.

[0033] As used herein, the term "vector" is used to describe a nucleic acid molecule that can be engineered to contain a polynucleotide or multiple polynucleotides that can be cloned and amplified in a host cell. Vectors include, but are not limited to: single-stranded, double-stranded or partially double-stranded nucleic acid molecules; nucleic acid molecules containing one or more free ends, no free ends (e.g., circular); nucleic acid molecules containing DNA, RNA or both; and other polynucleotide species known in the art. One type of vector is a "plasmid," which refers to a circular double-stranded DNA loop into which additional DNA fragments can be inserted, such as by standard molecular cloning techniques. Certain vectors are capable of autonomous replication in the host cell into which they are introduced (e.g., bacterial vectors and episomal mammalian vectors having a bacterial origin of replication). Other vectors (e.g., non-episomal mammalian vectors) are integrated into the genome of the host cell after introduction into the host cell, thereby replicating with the host genome. In addition, certain vectors are capable of directing the expression of those genes to which they are operably linked. Such vectors are referred to herein as "expression vectors." The recombinant expression vector may contain the nucleic acid of the present application in a form suitable for expressing the nucleic acid in a host cell, which means that the recombinant expression vector includes one or more regulatory elements, which can be selected based on the host cell used for expression and can be operably linked to the nucleic acid sequence to be expressed.

[0034] As used herein, the term "expression" includes any step involved in the production of the variant including, but not limited to, transcription, post-transcriptional modification, translation, post-translational modification, and secretion.

[0035] As used herein, the term "expression vector" means a linear or circular DNA molecule comprising a polynucleotide encoding a variant and operably linked to other nucleotides that provide for its expression.

[0036] As used herein, the term "host cell" means any cell type that is susceptible to transformation, transfection, transduction, etc. of a nucleic acid construct or expression vector comprising the polynucleotides of the present application. The term "host cell" encompasses any progeny of a parent cell that is not identical to the parent cell due to mutations that occur during replication. The host cell can be any cell useful in the production of recombinant human-like collagen of the present application.

[0037] In the following amino acid sequences and polypeptide sequences, capital letters such as I, P, V, Q, E, S, T, and W represent an amino acid or its amino acid residue. The correspondence between the capital letters and the amino acids is shown in Table 1.

[0038] Table 1 shows the amino acids and their corresponding abbreviations

[0039]

[0040]

[0041] The present application provides an amino acid sequence with anti-aging effect, the amino acid sequence is shown in SEQ ID NO.1, and the SEQ ID NO.1 is

[0042] GPPGGPGLGGQQGPRGPPGPSGTITLEVEPSDTIENVK.

[0043] The amino acid sequence is derived from sea cucumber.

[0044] The present application also provides a polypeptide with anti-aging effect, wherein the polypeptide comprises the following amino acid sequence: (GPPGGPGLGGQQGPRGPPGPSGTITLEVEPSDTIENVK) n , n is a positive integer from 1 to 5.

[0045] In some embodiments, when n is 1, the polypeptide comprises an amino acid sequence of GPGGPGLGGQQGPRGPPGPSGTITLEVEPSDTIENVK (SEQ ID NO. 1).

[0046] In some embodiments, when n is 2, the polypeptide comprises an amino acid sequence of GPGGPGLGGQQGPRGPPGPSGTITLEVEPSDTIENVKGPPGGPGLGGQQGPRGPPGPSGTITLEVEPS DTIENVK (SEQ ID NO. 2).

[0047] In some embodiments, when n is 3, the polypeptide comprises an amino acid sequence of GPGGPGLGGQQGPRGPPGPSGTITLEVEPSDTIENVKGPPGGPGLGGQQGPRGPPGPSGTITLEVEPS DTIENVKGPPGGPGLGGQQGPRGPPGPSGTITLEVEPSDTIENVK (SEQ ID NO. 3).

[0048] In some embodiments, when n is 4, the polypeptide comprises an amino acid sequence of GPPGGPGLGGQQGPRGPPGPSGTITLEVEPSDTIENVKGPPGGPGLGGQQGPRGPPGPSGTITLEVEPS DTIENVKGPPGGPGLGGQQGPRGPPGPSGTITLEVEPSDTIENVKGPPGGPGLGGQQGPRGPPGPSGTITLEVEPSDTIENVKGPPGGPGLGGQQGPRGPPGPSGT ITLEVEPSDTIENVK (SEQ ID NO.4).

[0049] In some embodiments, when n is 5, the polypeptide comprises an amino acid sequence of GPPGGPGLGGQQGPRGPPGPSGTITLEVEPSDTIENVKGPPGGPGLGGQQGPRGPPGPSGTITLEVEPS DTIENVKGPPGGPGLGGQQGPRGPPGPSGTITLEVEPS DTIENVKGPPGGPGLGGQQGPRGPPGPSGT ITLEVEPSDTIENVKGPPGGPGLGGQQGPRGPPGPSGTITLEVEPSDTIENVK(SEQ ID NO.5).

[0050] In the present application, the amino acid sequence or polypeptide is derived from sea cucumber. In some embodiments, the amino acid sequence or polypeptide is obtained by hydrolyzing sea cucumber by enzymatic hydrolysis.

[0051] The present application also provides a nucleic acid sequence of the aforementioned amino acid sequence or the aforementioned polypeptide.

[0052] The nucleotide sequence of the recombinant sea cucumber peptide with anti-aging effect is as follows:

[0053] (GGTCCACCAGGTGGTCCAGGTTTGGGTGGTCAACAAGGTCCAAGAGGTCCACCAGGTCCA TCTGGTACTATTACTTTGGAAGTTGAACCATCTGATACTATTGAAAACGTTAAG) n, n is a positive integer from 1 to 5, and the optimal value is n=2.

[0054] In some embodiments, when n is 1, the nucleotide sequence of the recombinant sea cucumber peptide with anti-aging effect is

[0055] GGTCCACCAGGTGGTCCAGGTTTGGGTGGTCAACAAGGTCCAAGAGGTCCACCAGGTCCA TCTGGTACTATTACTTTGGAAGTTGAACCATCTGATACTATTGAAAACGTTAAG (SEQ ID NO. 6).

[0056] In some embodiments, when n is 2, the nucleotide sequence of the recombinant sea cucumber peptide with anti-aging effect is

[0057] GGTCCACCAGGTGGTCCAGGTTTGGGTGGTCAAGGTCCAAGAGGTCCACCAGGTCCATCTGGTACTATTACTTTGGAAGTTGAACCATCTGATACTATTGAAAACGTTAAGGGTCCACCAGGTGGTCCAGGTTTGGGTGGTCAACAAGGTCCAAGAGGTCCACCAGGTCCATCTGGTACTATTACTTTGGAAGTTGAACCATCTGATACTATTGAAAACGTTAAG (SEQ ID NO. 7).

[0058] In some embodiments, when n is 3, the nucleotide sequence of the recombinant sea cucumber peptide with anti-aging effect is

[0059] GGTCCACCAGGTGGTCCAGGTTTGGGTGGTCAACAAGGTCCAAGAGGTCCACCAGGTCCATCTGGTACTATTACTTTGGAAGTTGAACCATCTGATACTATTGAAAACGTTAAGGGTCCACCAGGTGGTCCAGGTTTGGGTGGTCAACAAGGTCCAAGAGGTCCACCAGGTCCATCTGGTACTATTACTTTGGAAGTTGAACCATCTGATACTATTGAAAACGTTAAGGGTCCACCAGGTGGTCCAGGTTTGGGTGGTCAACAAGGTCCAAGAGGTCCACCAGGTCCATCTGGTACTATTACTTTGGAAGTTGAACCATCTGATACTATTGAAAACGTTAAG(SEQ ID NO.8).

[0060] In some embodiments, when n is 4, the nucleotide sequence of the recombinant sea cucumber peptide with anti-aging efficacy is

[0061] GGTCCACCAGGTGGTCCAGGTTTGGGTGGTCAACAAGGTCCAAGAGGTCCACCAGGTCCATCTGGTACTATTACTTTGGAAGTTGAACCATCTGATACTATTGAAAACGTTAAGGGTCCACCAGGTGGTCCAGGTTTGGGTGGTCAACAAGGTCCAAGAGGTCCACCAGGTCCATCTGGTACTATTACTTTGGAAGTTGAACCATCTGATACTATTGAAAACGTTAAGGGTCCACCAGGTGGTCCAGGTTTGGGTGGTCAACAAGGTCCAAGAGGTCCACCAGGTCCATCTGGTACTATTACTTTGGAAGTTGAACCATCTGATACTATTGAAAACGTTAAGGGTCCACCAGGTGGTCCAGGTTTGGGTGGTCAACAAGGTCCAAGAGGTCCACCAGGTCCATCTGGTACTATTACTTTGGAAGTTGAACCATCTGATACTATTGAAAACGTTAAG(SEQ ID NO.9).

[0062] In some embodiments, when n is 5, the nucleotide sequence of the recombinant sea cucumber peptide with anti-aging efficacy is

[0063] (SEQ ID NO.10).

[0064] In some embodiments, the amino acid sequence or polypeptide can be produced by chemical synthesis. In some embodiments, the polypeptide can be produced by biosynthesis. In some embodiments, the polypeptide can be extracted from food or obtained by enzymatic hydrolysis.

[0065] The present application provides a method for preparing a polypeptide, wherein the polypeptide is the aforementioned polypeptide.

[0066] In this application, the method comprises:

[0067] The polypeptide is obtained by expressing and purifying Pichia pastoris, and the Pichia pastoris carries an expression vector having the nucleotide sequence of the polypeptide.

[0068] Pichia pastoris is a unicellular fungus belonging to the family Saccharomyces. The Pichia pastoris ferments under anaerobic conditions. Its cell morphology is usually elliptical or spherical, with a diameter of 2 to 4 microns, and sometimes pseudohyphae are formed. The optimal growth temperature of Pichia pastoris is 28 to 30°C, but it can also grow at 37°C. The Pichia pastoris has an AOX1 gene, which is a methanol utilization gene of Pichia pastoris. The promoter of the AOX1 gene is one of the promoters with the strongest regulatory mechanism and the strictest regulation mechanism. At the same time, the constructed Pichia pastoris can be stably integrated in the form of a single copy or multiple copies at a specific site of the genome of Pichia pastoris, and the strain of Pichia pastoris is easy to ferment at a high density, with a high expression of exogenous proteins. There are also peroxisomes in Pichia pastoris, in which the expressed proteins are stored, which can be protected from degradation by proteases and reduce toxic effects on cells.

[0069] The Pichia pastoris is Pichia pastoris GS115.

[0070] The Pichia pastoris GS115 strain is a yeast commonly used in biotechnology and protein expression systems. It has an AOX1 gene, which can be normally expressed to produce an enzyme that converts methanol into formaldehyde, and is a normal methanol-utilizing yeast.

[0071] In a specific embodiment, the expression vector is pPIC9K.

[0072] The pPIC9K plasmid is a plasmid used in the expression system of Escherichia coli, and is usually used to express foreign genes in Escherichia coli. pPIC9K contains a selection marker, which is mainly used to screen and maintain the presence of the plasmid in the culture medium of Pichia pastoris. A selection marker is a gene or DNA fragment that allows only cells with a specific plasmid to grow and reproduce. pPIC9K usually contains multiple cloning sites, allowing researchers to insert foreign genes of interest into it. These sites are usually located around some restriction enzyme cutting sites to facilitate the insertion of DNA fragments.

[0073] In a specific embodiment, the method for preparing the polypeptide is: codon optimization of the amino acid sequence or the polypeptide to obtain a nucleic acid sequence encoding the amino acid sequence or the polypeptide sequence; connecting the nucleic acid sequence with the vector pPIC9K to obtain a recombinant vector; electroporating the recombinant vector into Pichia pastoris GS115 to obtain a recombinant Pichia pastoris; inducing fermentation of the recombinant Pichia pastoris to obtain the polypeptide.

[0074] In a specific embodiment, the induced culture is induced culture using methanol.

[0075] The present application provides the use of the aforementioned amino acid sequence or the aforementioned polypeptide or the polypeptide prepared by the aforementioned method in the preparation of cosmetics.

[0076] The present application provides a skin care product, which is composed of raw materials in the mass ratio shown in Table 2 below.

[0077] Table 2

[0078]

[0079] Example

[0080] The experimental methods used in the following examples are all conventional methods unless otherwise specified.

[0081] Unless otherwise specified, the materials and reagents used in the following examples can be obtained from commercial sources.

[0082] Example 1 Extraction of sea cucumber polypeptides

[0083] 1) Take fresh sea cucumber, remove the mouth, internal organs and inner membrane, wash and crush, and weigh 1 kg.

[0084] 2) Add 6 kg of ultrapure water, adjust the pH to 7.0, add 1% neutral protease, and control the enzymatic hydrolysis at 27° C. for 8 hours.

[0085] 3) heating the hydrolyzate at 100° C. for 40 minutes to inactivate the enzyme, and cooling to room temperature to obtain a sea cucumber enzymatic hydrolyzate;

[0086] 4) Add 95% ethanol to the sea cucumber hydrolysate until the ethanol volume fraction is 80%, and let it stand for 12 hours.

[0087] 5) Centrifuge at 10000rpm for 30 minutes.

[0088] 6) Recovering the ethanol in the supernatant, and decolorizing and removing the fishy smell of the sea cucumber polypeptide mixture through an anionic resin to obtain a sea cucumber polypeptide extract.

[0089] 7) Use a dialysis bag to perform desalination at 4°C.

[0090] The extract is placed in liquid nitrogen for rapid freezing and drying to obtain sea cucumber polypeptide freeze-dried powder.

[0091] Example 2: Screening of polypeptide sequences with anti-aging effects

[0092] Take the sea cucumber polypeptide freeze-dried powder obtained in Example 1 and dissolve it in 1% formic acid solution. Use orbital ion trap mass spectrometer (Thermo, America) for analysis. The flow rate is 0.300μl / min, and the analytical column is Acclaim PepMap RSLC column (75μm ID, 250mm length, C18). The mobile phase A is composed of 0.1% formic acid-water, and the mobile phase B is composed of 80% acetonitrile and 0.1% formic acid. Gradient elution conditions: 0-5min, 3% B; 5-80min, 22% B; 80-92min, 35% B; 92-103min, 90% B; 103-109min, 90% B; 109-110min, 3% B. The scanning range is 600-10000 m / z, the resolution is 60000, and the results are as follows Figure 1 as well as Figure 2 shown.

[0093] Screening of peptide sequences with anti-aging effects:

[0094] Orbitrap-MS analysis was performed on the freeze-dried sea cucumber powder. By searching the corresponding ncbi sea cucumber protein database, a total of 327 peptide spectra, 74 proteins, 24 proteomes, and 197 peptides were obtained. 98.98% of the peptides have a theoretical molecular weight of 800Da to 2000Da. The MS / MS spectra were searched according to the selected sea cucumber protein database using the software byonic (version 3.2.0). GO analysis (Gene Ontology (GO)) was performed on the 74 proteins using the GO tool provided by the UniProt community (http: / / www.uniprot.org / ). 64 IDs were expressed, 8 molecular functions were obtained, 11 biological processes were involved, and 5 cell components were present. The sea cucumber polypeptide sequence with anti-aging effect was screened as shown in SEQ ID NO.1.

[0095] Example 3: Determination of the anti-aging properties of sea cucumber peptides

[0096] Principle of anti-aging performance measurement: Matrix metalloproteinase (MMPs): MMP1 and MMP3 are members of the matrix metalloproteinase family, which can degrade various types of collagen and extracellular matrix molecules, and are important causes of skin sagging and wrinkles. UV irradiation can induce fibroblasts in the dermis to secrete MMP-1 and MMP-3. By measuring the amount of MMP-1 and MMP-3 secreted by Fbs cells, the anti-wrinkle effect of the sample can be reflected.

[0097] Cell viability: can reflect the metabolic activity and proliferation of cells. The amino acid sequence of the sea cucumber peptide in this example is shown in SEQ ID NO.1.

[0098] 1. Cytotoxicity assay

[0099] Unless otherwise specified, primary human skin-derived fibroblasts of the P5-P8 generations were selected for the experiment. Under sterile conditions, the sea cucumber peptide samples were prepared with serum-free culture medium and diluted to 5%, 2%, 1%, 0.5%, 0.2%, 0.1%, 0.05%, and 0.02% (w / v), and stored at 4°C for later use. Primary human skin-derived fibroblasts were inoculated in a 96-well plate and cultured under saturated humidity, 5% carbon dioxide, and 37°C. When the cell density was about 50%, the sample was added. 24 hours after the sample addition, the cell metabolic activity was detected by the CCK-8 method, and the cell survival rate was calculated according to the following formula. The results are shown in Table 4. The specific groupings are as follows

[0100] Table 3.

[0101]

[0102] Table 3 shows the cytotoxicity detection groups and detection indicators of this example.

[0103]

[0104] Table 4 shows the cytotoxicity test results in this example.

[0105]

[0106] Summary: From the above, it can be seen that the survival rate of cells is higher when the sea cucumber peptide samples of the present application are used to culture cells. Therefore, the sea cucumber peptides of the present application are safe and non-toxic.

[0107] 2. MMP-1 and MMP-3 cell viability detection

[0108] According to the results of cytotoxicity test, three sea cucumber peptide sample concentrations were selected as the test concentrations for efficacy experiments. Primary fibroblasts from human skin were inoculated in 24-well plates and cultured under saturated humidity, 5% carbon dioxide, and 37°C. The next day, samples were added according to the description in the table below, and UVA irradiation was performed 4 hours later, with an irradiation dose of 4.8 J / cm 2 After UVA irradiation, each well was replaced with fresh culture medium containing the test substance and cultured for 20 hours under saturated humidity, 5% carbon dioxide, and 37°C. At the end of the time, the supernatant of the culture medium in each well was collected and centrifuged. The secretion of MMP-1 and MMP-3 in each well was detected according to the operating instructions of the MMP-1 and MMP-3 detection kits, and the inhibition rate was calculated; at the same time, the cell viability of each well was detected using the CCK8 method, and the cell proliferation rate was calculated. The experimental groups are shown in Table 5, and the experimental results are shown in

[0109] Table 6-Table 8.

[0110]

[0111] Table 5 shows the experimental groups and detection indicators in this embodiment.

[0112]

[0113] Table 6 shows the results of MMP-1 secretion detection

[0114]

[0115] ##: compared with the blank control group, p<0.01; **: compared with the UV irradiation group, p<0.01;

[0116] Table 7 shows the results of MMP-3 secretion detection

[0117]

[0118] ##: compared with the blank control group, p<0.01; *: compared with the UV irradiation group, p<0.05; **: compared with the UV irradiation group, p<0.01;

[0119] Table 8 shows the results of cell viability test.

[0120]

[0121] ##: compared with the blank control group, p<0.01; **: compared with the UV irradiation group, p<0.01;

[0122] Summary: Recombinant sea cucumber peptide can significantly inhibit the expression of MMP-1 and MMP-3 caused by UV irradiation. The inhibition rate of 2% sea cucumber peptide on MMP-1 expression reached 50.6%±2.06%, and the inhibition rate of 2% sea cucumber peptide on MMP-3 expression reached 66.5%±2.7%. At the same time, the sea cucumber peptide sample can significantly inhibit the decrease in cell viability caused by UV irradiation.

[0123] Example 4 Preparation of recombinant sea cucumber peptide

[0124] The amino acid sequence of the recombinant sea cucumber peptide in this example is SEQ ID NO. 1. The following specifically describes the steps for synthesizing the recombinant sea cucumber peptide using genetically engineered bacteria.

[0125] 1. Synthesis of plasmid

[0126] The amino acids of the above Shanghai ginseng peptide were reverse translated and optimized according to the preference of Pichia codons. The nucleotide sequence was SEQ ID NO.6. The receptor was Pichia GS115, the vector was pPIC9K, the restriction sites were EcoRI and NotI, and the plasmid was commissioned to Beijing Qingke Biotechnology Co., Ltd. for synthesis. The plasmid structure is shown in Figure 3 .

[0127] 2. Linearization of plasmid

[0128] 1) Prepare the vector enzyme digestion system according to Table 9:

[0129] 2) Enzyme digestion at 37℃ overnight;

[0130] 3) Agarose gel electrophoresis detection, using the undigested plasmid as a control;

[0131] 4) After successful enzyme digestion, inactivate at 65°C for 20 min.

[0132] Table 9

[0133]

[0134] 3. Linearized plasmid purification and recovery

[0135] 1) Configure the vector purification system according to Table 10:

[0136] Table 10

[0137]

[0138] 2) Stand at -20℃ for more than 35 minutes;

[0139] 3) Centrifuge at 12000 rpm for 15 min at 4°C and discard the supernatant. A white precipitate can be observed on the wall.

[0140] 4) Add 400 μl of pre-cooled 80% ethanol to resuspend the precipitate;

[0141] 5) Centrifuge at 12000 rpm for 10 min at 4°C, discard the supernatant, and dry the tube;

[0142] 6) Add 10 μl ddH2O to dissolve the precipitate.

[0143] 4. Preparation of GS115 sea cucumber peptide

[0144] 1) Streak the strain onto a YPD plate and culture at 30°C for 3-5 days until a single colony grows;

[0145] 2) Pick a single clone and transfer it to 10 mL YPD culture medium (125 mL conical flask), and culture at 30°C and 300 rpm for 1-2 days;

[0146] 3) Transfer to 100 mL YPD culture medium, with an initial bacterial concentration of OD600 = 0.2, and culture at 30°C and 300 rpm for 1-2 days until OD600 = 1.3-1.5; (Note: When the OD value cannot be determined, transfer to different concentrations for culture)

[0147] 4) Centrifuge at 1500g for 5 min at 4°C to collect the bacterial strains, and add 250 mL of pre-cooled sterile water to resuspend the bacterial strains to wash the bacterial strains;

[0148] 5) Centrifuge at 1500g for 5 min at 4°C to collect the bacteria (adjust the deceleration damping to greater than 6), add 10 mL of pre-cooled 1 M sorbitol to resuspend the bacteria, and gently pipette during resuspending;

[0149] 6) Collect the culture by centrifugation at 1500g and 4℃ for 5 min (adjust the deceleration damping to greater than 6), add 300μl pre-cooled 1M sorbitol to resuspend the culture, gently blow during resuspending, the final volume of the culture is about 500μl (in actual operation, the final volume of the culture is about 700μl), divide into 100μl per tube, and place on ice for electroporation.

[0150] 5. Electrical conversion

[0151] 1) Take 80 μl of competent cells, add 6 μg of linearized pPIC9K, mix well and transfer to a pre-cooled 0.2 cm electroporation cuvette;

[0152] 2) Place on ice for 5 minutes;

[0153] 3) Electric shock according to the yeast electric shock parameter settings (1.5 kV, 25 μF, 200 Ω);

[0154] 4) Immediately add 2 ml of pre-cooled 1 M sorbitol + HEPES (10 ml 1 M sorbitol + 100 μl 2 M HEPES, pH = 8.0) and transfer to a 2 ml sterile centrifuge tube;

[0155] 5) Incubate at 30°C for 1-2 hours;

[0156] 6) After diluting 5-fold, 10-fold, and 100-fold, 300 μl / plate was spread on a 15 cm YPD plate containing 100 mg / l Zeocin, and cultured at 30°C until clones grew.

[0157] 6. Positive clone screening

[0158] 1) Use a 10 μl pipette tip to streak the clones grown on the MD plate onto a 0.5 mg / mL G418 plate and culture at 30°C for 3-5 days;

[0159] 2) Select clones with better growth and streak them onto 2 mg / mL and 4 mg / mL G418 plates at the same time, and culture at 30°C for 3-5 days;

[0160] 3) Try to select 5 clones that grow better on the 4 mg / mL G418 plate to try to induce expression. If the growth on the 4 mg / mL plate is poor, select the clones on the 2 mg / mL plate.

[0161] 7. Transformant expression test

[0162] 1) Prepare 7 50 ml conical flasks, add 5 ml YPG medium to each, inoculate the above verified clones respectively, and culture at 30°C and 220 rpm for 1-2 days until the bacterial solution is saturated;

[0163] 2) Transfer to a 50 ml centrifuge tube, centrifuge at 4000 rpm for 5 min, and discard the supernatant;

[0164] 3) Resuspend the cells in 5 ml BMMY medium, transfer to a new sterile 50 ml conical flask, add methanol to a final concentration of 0.5%, and culture at 28°C and 220 rpm for 6 days;

[0165] 4) Methanol was added every 24 h (final concentration was 0.5%);

[0166] 5) On the morning of the 6th day, the bacterial culture was collected, centrifuged at 4000 rpm for 5 min, and the supernatant was collected;

[0167] 6) Screen the strain with ideal expression and preserve the glycerol bacteria (the ratio of bacterial liquid to 20% glycerol is 1:1).

[0168] 8. Expression

[0169] 1) 10L fermentation tank, the culture medium is BSM medium, prepared as follows:

[0170] Fermentation medium: including 26.7 ml / L of 85% phosphoric acid, 18.2 g / L of KOH, 1.18 g / L of CaSO4·2H2O, 18.2 g / L of K2SO4, 14.9 g / L of MgSO4·7H2 O, and 40 g / L of glycerol; after the fermentation medium is sterilized at high temperature and the temperature drops to room temperature, PTM1 is added and the pH is adjusted to 5.0 with aqueous ammonia.

[0171] Feed medium: 50% W / V glycerol, plus 12 mL PTM1 trace elements per liter;

[0172] Induction medium: 100% methanol, plus 12mL PTM1 trace elements per liter.

[0173] 2) Fermentation control: liquid volume 5L, temperature controlled at 28°C, dissolved oxygen controlled to be greater than 30% by stirring speed and air flow, maximum stirring speed 800rpm, maximum air flow controlled at 6L / min.

[0174] 3) Induction: Control the wet weight of the bacteria to about 150 g / L for induction, first starve for 0.5-1 h, then induce with methanol, add methanol intermittently, control the methanol concentration to 0.5-1% for induction, and induce for 90-120 h.

[0175] 9. Purification

[0176] 1) After the fermentation, solid-liquid separation was performed by centrifugation at 6000 rpm for 10 min, and the supernatant was collected.

[0177] 2) Ultrafiltration desalination: use an organic membrane with a molecular weight of 500Da for ultrafiltration desalination.

[0178] 3) Ion chromatography, protein PI = 4.1, select Q BB column, buffer A: 50 mM phosphate buffer, pH = 7; buffer B: 50 mM phosphate buffer + 1 M sodium chloride, pH = 7;

[0179] 4) Ultrafiltration desalination: use an organic membrane with a molecular weight of 500Da for ultrafiltration desalination.

[0180] 5) Freeze-drying. The hydrophilicity of recombinant sea cucumber peptide is shown in Figure 4 .

[0181] Example 5: A lifting and repairing skin base lotion

[0182] The formula of the lifting and repairing base lotion in this embodiment is shown in Table 11 below.

[0183] Table 11 is the formula of the lifting and repairing skin base lotion

[0184] Raw material serial number Standard Chinese name Addition amount / g 1 water 55.0 2 Caprylic / capric triglyceride 4.6 3 glycerin 4.2 4 Butanediol 3.8 5 Isononyl Isononanoate 2.1 6 Squalane 2.0 7 Avocado tree (BUTYROSPERMUMPARKII) butter 1.5 8 Tridecyl trimellitate 1.3 9 Oat (AVENASATIVA) β-Glucan 1.3 10 C14-22 alcohol, C12-20 alkyl glucoside 0.8 11 Cetearyl Olivate, Sorbitan Olivate 0.8 12 Cetearyl Alcohol 0.5 13 Dimethicone 0.4 14 Dipropylene glycol 0.4 15 Tocopheryl acetate 0.4 16 p-Hydroxyacetophenone 0.2 17 1,2-Hexanediol 0.2 18 Panthenol 0.2 19 Acrylates / C10-30 Alkyl Acrylate Crosspolymer 0.015 20 Arginine 0.015 21 Biotin 0.015 22 Magnolia 0.010 23 Xanthan gum 0.009 24 Allantoin 0.009 25 Dipotassium glycyrrhizinate 0.008 26 Sea cucumber peptide ((SEQ ID NO.1)) 0.008 27 Ceramide NP 0.006 28 Gynostemma pentaphyllum extract 0.002

[0185] 1. Prepare the lifting and repairing base lotion according to the formula in Table 11. The specific method is as follows:

[0186] Raw materials for phase A1: water (1 / 3 of the content in the formula), acrylic acid (esters) / C10-30 alkyl acrylate crosslinked polymer.

[0187] A2 phase raw materials: butanediol and magnolol.

[0188] Ingredients for phase A3: Water (the remaining amount in the formula), glycerin, dipropylene glycol, p-hydroxyacetophenone, 1,2-hexanediol, panthenol, xanthan gum, allantoin, Gynostemma PENTAPHYLLUM extract.

[0189] Phase B ingredients: caprylic / capric triglyceride, isononyl isononanoate, squalane, avocado tree (BUTYROSPERMUMPARKII) fruit butter, tridecyl trimellitate, C14-22 alcohol, C12-20 alkyl glucoside, cetearyl olivate, sorbitan olivate, cetearyl alcohol, polydimethylsiloxane, tocopheryl acetate, sea cucumber extract.

[0190] Phase C raw materials: arginine.

[0191] Phase D ingredients: oat (AVENA SATIVA) β-glucan, biotin, dipotassium glycyrrhizinate, and ceramide NP.

[0192] 1) Weigh the raw materials of Formulation A1 and swell overnight until the material is transparent and uniform;

[0193] 2) Weigh the raw materials of phase A2 and mix them evenly for later use;

[0194] 3) Weigh phase A3 and add them into the main pot in sequence, add the dispersed phase A1 raw materials into the main pot, add the phase A2 raw materials into the main pot, start stirring and heat up to 85±3℃, keep warm for 30min, open the pot and check until the material is dissolved and transparent without insoluble matter, set aside;

[0195] 4) Weigh the raw materials of phase B, add them into the oil pan in sequence, stir and heat to 85±3℃, keep warm and stir for 30 minutes, check the dissolution of the liquid, and wait until the material is dissolved evenly, and set aside;

[0196] 5) Emulsification: Pump the raw materials of phase B into phase A, stir until the material is uniform, start homogenization, homogenize for 8-12 minutes, open the pot to check the emulsification effect, and start cooling until the material liquid is uniform;

[0197] 6) The temperature drops to 70±3℃, and the vacuum is turned on. The vacuum is maintained between -0.06 and -0.08KPa for 20 minutes;

[0198] 7) When the temperature drops to 60±3°C, weigh the raw materials of phase C, add them into the pot, and stir until the material is uniform;

[0199] 8) When the temperature drops to 40±3°C, weigh the raw materials of phase D, add them into the pot in sequence, and stir until the material is uniform;

[0200] 9) The temperature is lowered to 35±3° C., stirring is stopped, and the material is taken for testing. The material is discharged after it passes the test, thereby obtaining the lifting and repairing skin base liquid of this embodiment.

[0201] 2. Performance test of the lifting and repairing base lotion of this embodiment

[0202] We recruited 30 to 60-year-olds with facial skin that meets the requirement of Tewl>15g / h / m 232 subjects with stratum corneum moisture content <50 (Corneometer Unit, CU) used the lifting and repairing base solution of this embodiment for 28 consecutive days. The specific method of use is to take the required amount on the palm of your hand after cleansing or using toner in the morning / evening, warm the base solution with the palms facing each other, and evenly apply it on the face / neck, and gently press until absorbed. The moisturizing, repairing, and firming effects of cosmetics are evaluated by testing the changes in the stratum corneum moisture content, transepidermal water loss rate, and skin firmness of the subjects before and after 28 days of use of the lifting and repairing base solution.

[0203] The moisture content of the stratum corneum was measured on the cheeks of the subjects using a skin moisture tester, Probe Corneometer CM825 (CK, Germany). The higher the test value, the more hydrated the skin.

[0204] The transepidermal water loss rate of the skin was tested on the cheeks of the subjects using the transepidermal water loss TEWL and water evaporation heat loss test probe ProbeTewameter TM Hex (CK, Germany). The lower the test value, the better the skin barrier function.

[0205] Skin firmness was tested on the cheeks of the subjects using a skin elasticity tester, Cutometer Dual MPA580 (CK, Germany). The lower the skin firmness (RO) value, the tighter the skin.

[0206] During the test, the instrument testing phase should be carried out under the environmental conditions of 21±1℃ and 50±10%RH, and all subjects should sit still and balance for at least 30 minutes under this environmental condition before starting the evaluation and testing. Figure 5-Figure 7 .

[0207] Summary: Figure 5 It can be seen that after using the test product continuously for 28 days, the moisture content of the subjects' skin stratum corneum increased significantly compared with the baseline value (P≤0.001), and the change rate of the moisture content of the subjects' skin stratum corneum compared with the baseline value after using the test product continuously for 28 days was 28.11%.

[0208] Depend on Figure 6 It can be seen that after using the test product continuously for 28 days, the subjects' transepidermal water loss rate was significantly decreased compared with the baseline value (P≤0.001). After using the test product continuously for 28 days, the change rate of the subjects' transepidermal water loss rate compared with the baseline value was -7.19%.

[0209] Depend on Figure 7It can be seen that after 28 days of continuous use of the test product, the skin firmness (RO) of the subjects showed a significant decrease compared with the baseline value (0.01 < P ≤ 0.05), and the change rate of the skin firmness (RO) of the subjects after 28 days of continuous use of the test product compared with the baseline value was -7.44%.

[0210] Although the embodiments of the present application have been described above, the present application is not limited to the above specific embodiments and application fields. The above specific embodiments are merely illustrative and guiding, rather than restrictive. Those of ordinary skill in the art can also make many forms under the inspiration of this specification and without departing from the scope protected by the claims of the present application, and these all belong to the scope of protection of the present application.

Claims

1. An amino acid sequence with anti-aging effects, wherein: The amino acid sequence is SEQ ID NO.1, and the SEQ ID NO.1 is GPGGPGLGGQQGPRGPPGPSGTITLEVEPSDTIENVK.

2. The amino acid sequence according to claim 1, wherein The amino acid sequence is derived from sea cucumber.

3. A polypeptide with anti-aging effect, wherein: The polypeptide comprises the following amino acid sequence: (GPPGGPGLGGQQGPRGPPGPSGTITLEVEPSDTIENVK) n , n is 1, 2, 3, 4 or 5.

4. The polypeptide according to claim 3, wherein The polypeptide is derived from sea cucumber.

5. A nucleotide sequence encoding the amino acid sequence of claim 1 or 2 or the polypeptide of claim 3 or 4.

6. The nucleotide sequence according to claim 5, wherein The nucleotide sequence is SEQ ID NO.6, and the SEQ ID NO.6 is GGTCCACCAGGTGGTCCAGGTTTGGGTGGTCAACAAGGTCCAAGAGGTCCAC CAGGTCCATCTGGTACTATTACTTTGGAAGTTGAACCATCTGATACTATTGAAAAC GTTAAG.

7. A method for preparing a polypeptide, wherein: The polypeptide is the polypeptide according to claim 3 or claim 4.

8. The method according to claim 7, wherein: include: The polypeptide is expressed and purified by using Pichia pastoris, and the Pichia pastoris carries an expression vector having the nucleotide sequence of the polypeptide.

9. The method according to claim 8, wherein: The Pichia pastoris is Pichia pastoris GS115, and preferably the expression vector is pPIC9K.

10. Use of the amino acid sequence of claim 1 or 2, or the polypeptide of claim 3 or 4, or the polypeptide prepared by the method of any one of claims 7 to 9 in the preparation of cosmetics.

11. A cosmetic comprising the amino acid sequence of claim 1 or 2, or the polypeptide of any one of claims 3 or 4, or a polypeptide prepared by the method of any one of claims 7 to 9.

Citation Information

Patent Citations

  • Recombinant stichopus japonicus collagen polypeptide as well as preparation method and application thereof

    CN109867721A

  • Application and preparation method of sea cucumber polypeptide in medical equipment

    CN110613832A

  • Data analysis method and device for obtaining preparation process of sea cucumber polypeptide extract

    CN115357714A

  • Anti-aging oligopeptide and preparation method thereof

    CN116041440A

  • Sea cucumber-derived polypeptide with moisturizing function

    CN117820433A

Cited By

  • Sea cucumber peptide-honokiol liposome as well as preparation method and application thereof

    CN121102048A

  • Anti-inflammatory composition and application thereof

    CN121129707A

  • Preparation method and application of III-type human collagen

    CN121873185A

  • A method for preparing type III human collagen and its application

    CN121873185B